Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)
March 15 2019 - 8:15AM
Edgar (US Regulatory)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Globe House
|
|
|
|
|
4 Temple Place
|
|
|
|
|
London WC2R 2PG
|
|
|
|
|
United Kingdom
|
|
|
|
|
|
|
|
Tel: +44 (0)20 7845 1000
|
|
|
|
|
Fax: +44 (0)20 7240 0555
|
|
|
|
|
www.bat.com
|
|
|
|
|
|
|
|
|
|
|
US Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
15 March 2019
Re: Notice of disclosure filed in Exchange
Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
Ladies and Gentlemen:
Pursuant to Section 219 of the Iran
Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that British American Tobacco p.l.c. has made disclosure pursuant to those provisions in its
Annual Report on Form
20-F
for the year ended 31 December 2018 (page 289), which was filed with the Securities and Exchange Commission on 15 March 2019.
Respectfully submitted,
British American Tobacco p.l.c.
|
/s/ Paul McCrory
|
Paul McCrory
Company Secretary
|
British American Tobacco p.l.c. Registered in England
and Wales no. 3407696
Registered office: Globe House, 4 Temple Place, London WC2R 2PG
British American Tobacco (NYSE:BTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
British American Tobacco (NYSE:BTI)
Historical Stock Chart
From Apr 2023 to Apr 2024